{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T19:21:11Z","timestamp":1785439271839,"version":"3.56.0"},"reference-count":55,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,2,18]],"date-time":"2025-02-18T00:00:00Z","timestamp":1739836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,2,18]],"date-time":"2025-02-18T00:00:00Z","timestamp":1739836800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Qingdao Medical and Health Research Project","award":["NO.2022-WJZD002"],"award-info":[{"award-number":["NO.2022-WJZD002"]}]},{"name":"Qingdao Medical and Health Research Project","award":["NO.2022-WJZD002"],"award-info":[{"award-number":["NO.2022-WJZD002"]}]},{"name":"Qingdao Medical and Health Research Project","award":["NO.2022-WJZD002"],"award-info":[{"award-number":["NO.2022-WJZD002"]}]},{"name":"Qingdao Medical and Health Research Project","award":["NO.2022-WJZD002"],"award-info":[{"award-number":["NO.2022-WJZD002"]}]},{"name":"Qingdao Outstanding Health Professional Development Fund"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cardiovasc Disord"],"DOI":"10.1186\/s12872-025-04558-2","type":"journal-article","created":{"date-parts":[[2025,2,18]],"date-time":"2025-02-18T14:04:39Z","timestamp":1739887479000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Relationship between novel inflammatory markers derived from high-sensitivity C-reactive protein and heart failure: a cross-sectional study"],"prefix":"10.1186","volume":"25","author":[{"given":"Peng","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Degang","family":"Mo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fanhui","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongyan","family":"Dai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,2,18]]},"reference":[{"key":"4558_CR1","doi-asserted-by":"crossref","unstructured":"McDonagh TA, Metra M, Adamo M, Gardner RS, Baumbach A, B\u00f6hm M, et al. 2021 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure: developed by the Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC) with the special contribution of the Heart Failure Association (HFA) of the ESC. Revista Esp De cardiologia (English ed). 2021;75(6):523.","DOI":"10.1093\/eurheartj\/ehab670"},{"key":"4558_CR2","unstructured":"Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990\u20132017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet (London England). 2018;392(10159):1789\u2013858."},{"issue":"10","key":"4558_CR3","doi-asserted-by":"publisher","first-page":"1412","DOI":"10.1016\/j.cardfail.2023.07.006","volume":"29","author":"B Bozkurt","year":"2023","unstructured":"Bozkurt B, Ahmad T, Alexander KM, Baker WL, Bosak K, Breathett K, et al. Heart failure epidemiology and outcomes statistics: a report of the Heart Failure Society of America. J Card Fail. 2023;29(10):1412\u201351.","journal-title":"J Card Fail"},{"issue":"1","key":"4558_CR4","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1161\/CIRCRESAHA.116.308030","volume":"119","author":"SA Dick","year":"2016","unstructured":"Dick SA, Epelman S. Chronic heart failure and inflammation: what do we really know? Circul Res. 2016;119(1):159\u201376.","journal-title":"Circul Res"},{"key":"4558_CR5","doi-asserted-by":"crossref","unstructured":"Thorp EB, Filipp M. Contributions of inflammation to Cardiometabolic Heart failure with preserved ejection fraction. Annual review of pathology; 2024.","DOI":"10.1146\/annurev-pathmechdis-111523-023405"},{"issue":"3","key":"4558_CR6","first-page":"390","volume":"75","author":"Q Zhang","year":"2023","unstructured":"Zhang Q, Chen YE, Zhu XX, Wang X, Qu AJ. [The role of inflammation in heart failure with preserved ejection fraction]. Sheng Li Xue Bao. 2023;75(3):390\u2013402.","journal-title":"Sheng Li Xue Bao"},{"issue":"8","key":"4558_CR7","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1038\/s41577-019-0165-0","volume":"19","author":"KV Swanson","year":"2019","unstructured":"Swanson KV, Deng M, Ting JP. The NLRP3 inflammasome: molecular activation and regulation to therapeutics. Nat Rev Immunol. 2019;19(8):477\u201389.","journal-title":"Nat Rev Immunol"},{"key":"4558_CR8","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1111\/j.1749-6632.1982.tb22124.x","volume":"389","author":"I Kushner","year":"1982","unstructured":"Kushner I. The phenomenon of the acute phase response. Ann N Y Acad Sci. 1982;389:39\u201348.","journal-title":"Ann N Y Acad Sci"},{"issue":"5","key":"4558_CR9","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1016\/j.jacc.2023.05.035","volume":"82","author":"PM Burger","year":"2023","unstructured":"Burger PM, Koudstaal S, Mosterd A, Fiolet ATL, Teraa M, van der Meer MG, et al. C-Reactive protein and risk of Incident Heart failure in patients with Cardiovascular Disease. J Am Coll Cardiol. 2023;82(5):414\u201326.","journal-title":"J Am Coll Cardiol"},{"issue":"19","key":"4558_CR10","doi-asserted-by":"publisher","first-page":"e029386","DOI":"10.1161\/JAHA.123.029386","volume":"12","author":"L Zhang","year":"2023","unstructured":"Zhang L, He G, Huo X, Tian A, Ji R, Pu B, et al. Long-term cumulative high-sensitivity C-Reactive protein and mortality among patients with Acute Heart failure. J Am Heart Association. 2023;12(19):e029386.","journal-title":"J Am Heart Association"},{"key":"4558_CR11","doi-asserted-by":"crossref","unstructured":"Adorni MP, Ronda N, Bernini F, Zimetti F. High density lipoprotein cholesterol efflux capacity and atherosclerosis in Cardiovascular Disease: pathophysiological aspects and pharmacological perspectives. Cells. 2021;10(3).","DOI":"10.3390\/cells10030574"},{"issue":"1","key":"4558_CR12","doi-asserted-by":"publisher","first-page":"1482","DOI":"10.1096\/fj.201801245R","volume":"33","author":"P Keul","year":"2019","unstructured":"Keul P, Polzin A, Kaiser K, Gr\u00e4ler M, Dannenberg L, Daum G, et al. Potent anti-inflammatory properties of HDL in vascular smooth muscle cells mediated by HDL-S1P and their impairment in coronary artery disease due to lower HDL-S1P: a new aspect of HDL dysfunction and its therapy. FASEB Journal: Official Publication Federation Am Soc Experimental Biology. 2019;33(1):1482\u201395.","journal-title":"FASEB Journal: Official Publication Federation Am Soc Experimental Biology"},{"issue":"11","key":"4558_CR13","doi-asserted-by":"publisher","first-page":"321","DOI":"10.31083\/j.rcm2411321","volume":"24","author":"L Xing","year":"2023","unstructured":"Xing L, Liu Y, Wang J, Tian P, Liu P. High-density lipoprotein and heart failure. Rev Cardiovasc Med. 2023;24(11):321.","journal-title":"Rev Cardiovasc Med"},{"issue":"9","key":"4558_CR14","doi-asserted-by":"publisher","first-page":"e6094","DOI":"10.1097\/MD.0000000000006094","volume":"96","author":"Q Zhao","year":"2017","unstructured":"Zhao Q, Li J, Yang J, Li R. Association of total cholesterol and HDL-C levels and outcome in coronary heart disease patients with heart failure. Medicine. 2017;96(9):e6094.","journal-title":"Medicine"},{"key":"4558_CR15","doi-asserted-by":"publisher","first-page":"6251","DOI":"10.2147\/JIR.S481085","volume":"17","author":"A Abudouwayiti","year":"2024","unstructured":"Abudouwayiti A, Yisimayili S, Tuersun R, Aimaier S, Yisha D, Zhang XY, et al. HDL levels as a novel predictor of long-term adverse outcomes in patients with heart failure: a retrospective cohort study. J Inflamm Res. 2024;17:6251\u201364.","journal-title":"J Inflamm Res"},{"issue":"2","key":"4558_CR16","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1002\/eji.201040639","volume":"41","author":"YC Twu","year":"2011","unstructured":"Twu YC, Gold MR, Teh HS. TNFR1 delivers pro-survival signals that are required for limiting TNFR2-dependent activation-induced cell death (AICD) in CD8\u2009+\u2009T cells. Eur J Immunol. 2011;41(2):335\u201344.","journal-title":"Eur J Immunol"},{"key":"4558_CR17","doi-asserted-by":"publisher","first-page":"100981","DOI":"10.1016\/j.ijcha.2022.100981","volume":"39","author":"M Majmundar","year":"2022","unstructured":"Majmundar M, Kansara T, Park H, Ibarra G, Marta Lenik J, Shah P, et al. Absolute lymphocyte count as a predictor of mortality and readmission in heart failure hospitalization. Int J Cardiol Heart Vasculature. 2022;39:100981.","journal-title":"Int J Cardiol Heart Vasculature"},{"issue":"11","key":"4558_CR18","doi-asserted-by":"publisher","first-page":"859","DOI":"10.2459\/JCM.0000000000000428","volume":"18","author":"V Carubelli","year":"2017","unstructured":"Carubelli V, Bonadei I, Castrini AI, Gorga E, Ravera A, Lombardi C, et al. Prognostic value of the absolute lymphocyte count in patients admitted for acute heart failure. J Cardiovasc Med (Hagerstown Md). 2017;18(11):859\u201365.","journal-title":"J Cardiovasc Med (Hagerstown Md)"},{"issue":"11","key":"4558_CR19","doi-asserted-by":"publisher","first-page":"e13919","DOI":"10.1111\/1440-1681.13919","volume":"51","author":"XY Dai","year":"2024","unstructured":"Dai XY, Xue ZK, Wang XW, Chen KY, Hu ST, Tse G, et al. High-sensitivity C-reactive protein to high-density lipoprotein cholesterol ratio predicts long-term adverse outcomes in patients who underwent percutaneous coronary intervention: a prospective cohort study. Clin Exp Pharmacol Physiol. 2024;51(11):e13919.","journal-title":"Clin Exp Pharmacol Physiol"},{"issue":"1","key":"4558_CR20","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1186\/s12944-024-02055-7","volume":"23","author":"Y Gao","year":"2024","unstructured":"Gao Y, Wang M, Wang R, Jiang J, Hu Y, Wang W, et al. The predictive value of the hs-CRP\/HDL-C ratio, an inflammation-lipid composite marker, for cardiovascular disease in middle-aged and elderly people: evidence from a large national cohort study. Lipids Health Dis. 2024;23(1):66.","journal-title":"Lipids Health Dis"},{"issue":"3","key":"4558_CR21","doi-asserted-by":"publisher","first-page":"e00479","DOI":"10.1002\/edm2.479","volume":"7","author":"R Kolahi Ahari","year":"2024","unstructured":"Kolahi Ahari R, Akbari N, Babaeepoor N, Fallahi Z, Saffar Soflaei S, Ferns G, et al. Association of three novel inflammatory markers: lymphocyte to HDL-C ratio, high-sensitivity C-Reactive protein to HDL-C ratio and high-sensitivity C-Reactive protein to lymphocyte ratio with metabolic syndrome. Endocrinol Diabetes Metabolism. 2024;7(3):e00479.","journal-title":"Endocrinol Diabetes Metabolism"},{"issue":"6","key":"4558_CR22","doi-asserted-by":"publisher","first-page":"1221","DOI":"10.1536\/ihj.21-246","volume":"62","author":"H Luo","year":"2021","unstructured":"Luo H, Kou T, Yin L, High-Sensitivity C. -Reactive protein to HDL-C ratio. Int Heart J. 2021;62(6):1221\u20139.","journal-title":"Int Heart J"},{"key":"4558_CR23","doi-asserted-by":"publisher","first-page":"5591","DOI":"10.2147\/OTT.S167857","volume":"11","author":"M Liao","year":"2018","unstructured":"Liao M, Chen P, Liao Y, Li J, Yao W, Sun T, et al. Preoperative high-sensitivity C-reactive protein to lymphocyte ratio index plays a vital role in the prognosis of hepatocellular carcinoma after surgical resection. OncoTargets Therapy. 2018;11:5591\u2013600.","journal-title":"OncoTargets Therapy"},{"key":"4558_CR24","doi-asserted-by":"publisher","first-page":"131400","DOI":"10.1016\/j.ijcard.2023.131400","volume":"395","author":"H Zheng","year":"2024","unstructured":"Zheng H, Yin Z, Luo X, Zhou Y, Zhang F, Guo Z. Associations between systemic immunity-inflammation index and heart failure: evidence from the NHANES 1999\u20132018. Int J Cardiol. 2024;395:131400.","journal-title":"Int J Cardiol"},{"key":"4558_CR25","doi-asserted-by":"publisher","first-page":"702489","DOI":"10.3389\/fcvm.2021.702489","volume":"8","author":"Z Liu","year":"2021","unstructured":"Liu Z, Liu H, Deng Q, Sun C, He W, Zheng W, et al. Association between Dietary Inflammatory Index and Heart failure: results from NHANES (1999\u20132018). Front Cardiovasc Med. 2021;8:702489.","journal-title":"Front Cardiovasc Med"},{"issue":"1","key":"4558_CR26","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1186\/s12967-023-04307-z","volume":"21","author":"Y Han","year":"2023","unstructured":"Han Y, Cao Y, Han X, Di H, Yin Y, Wu J, et al. Hyperuricemia and gout increased the risk of long-term mortality in patients with heart failure: insights from the National Health and Nutrition Examination Survey. J Translational Med. 2023;21(1):463.","journal-title":"J Translational Med"},{"issue":"1","key":"4558_CR27","doi-asserted-by":"publisher","first-page":"716","DOI":"10.1186\/s12877-023-04324-z","volume":"23","author":"Z Jiang","year":"2023","unstructured":"Jiang Z, Wang J, Cai X, Wang P, Liu S. L-shaped association of serum \u03b1-Klotho and frailty among the middle-aged and older adults: results from NHANES 2007\u20132016. BMC Geriatr. 2023;23(1):716.","journal-title":"BMC Geriatr"},{"key":"4558_CR28","doi-asserted-by":"publisher","first-page":"171742","DOI":"10.1016\/j.scitotenv.2024.171742","volume":"925","author":"Y Wang","year":"2024","unstructured":"Wang Y, Zhang J, Zhang J, Hou M, Kong L, Lin X, et al. Association between per- and polyfluoroalkyl substances exposure and prevalence of chronic obstructive pulmonary disease: the mediating role of serum albumin. Sci Total Environ. 2024;925:171742.","journal-title":"Sci Total Environ"},{"key":"4558_CR29","doi-asserted-by":"publisher","first-page":"1331159","DOI":"10.3389\/fpubh.2023.1331159","volume":"11","author":"Y Chen","year":"2023","unstructured":"Chen Y, Huang R, Mai Z, Chen H, Zhang J, Zhao L, et al. Association between systemic immune-inflammatory index and diabetes mellitus: mediation analysis involving obesity indicators in the NHANES. Front Public Health. 2023;11:1331159.","journal-title":"Front Public Health"},{"issue":"1","key":"4558_CR30","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1186\/s12944-019-1157-6","volume":"18","author":"L Sun","year":"2019","unstructured":"Sun L, Liu X, Li W, Jia D. HDL-C to hsCRP ratio is associated with left ventricular diastolic function in absence of significant coronary atherosclerosis. Lipids Health Dis. 2019;18(1):219.","journal-title":"Lipids Health Dis"},{"issue":"5","key":"4558_CR31","first-page":"576","volume":"24","author":"CX Jiang","year":"2004","unstructured":"Jiang CX, Li ZL, Yan QN. [Detection of high-sensitivity C-reactive protein and total cholesterol\/high-density lipoprotein cholesterol ratio for diagnosis of coronary artery disease]. Di 1 Jun Yi da xue xue bao\u2009=\u2009academic. J First Med Coll PLA. 2004;24(5):576\u20138.","journal-title":"J First Med Coll PLA"},{"issue":"2","key":"4558_CR32","doi-asserted-by":"publisher","first-page":"207","DOI":"10.2174\/1567202620666230606120439","volume":"20","author":"Y Wang","year":"2023","unstructured":"Wang Y, Zhu Y, Wang X, Zhong C, Qin Y, Sun Y, et al. Combined role of inflammatory biomarkers and red blood cell distribution Width in Predicting In-hospital outcomes of Acute ischemic stroke patients undergoing thrombolysis. Curr Neurovasc Res. 2023;20(2):207\u201317.","journal-title":"Curr Neurovasc Res"},{"key":"4558_CR33","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1016\/j.cca.2020.07.050","volume":"510","author":"D Traxler","year":"2020","unstructured":"Traxler D, Zimmermann M, Simader E, Veraar CM, Moser B, Mueller T, et al. The inflammatory markers sST2, HSP27 and hsCRP as a prognostic biomarker panel in chronic heart failure patients. Clin Chim Acta. 2020;510:507\u201314.","journal-title":"Clin Chim Acta"},{"issue":"4","key":"4558_CR34","doi-asserted-by":"publisher","first-page":"390","DOI":"10.2174\/1570161115666170404121619","volume":"15","author":"S Kang","year":"2017","unstructured":"Kang S, Fan LY, Chen M, Li J, Liu ZM. Relationship of high-sensitivity C-Reactive protein concentrations and systolic heart failure. Curr Vasc Pharmacol. 2017;15(4):390\u20136.","journal-title":"Curr Vasc Pharmacol"},{"issue":"9","key":"4558_CR35","doi-asserted-by":"publisher","first-page":"1141","DOI":"10.1016\/j.metabol.2006.04.004","volume":"55","author":"L Jia","year":"2006","unstructured":"Jia L, Long S, Fu M, Yan B, Tian Y, Xu Y, et al. Relationship between total cholesterol\/high-density lipoprotein cholesterol ratio, triglyceride\/high-density lipoprotein cholesterol ratio, and high-density lipoprotein subclasses. Metab Clin Exp. 2006;55(9):1141\u20138.","journal-title":"Metab Clin Exp"},{"issue":"21","key":"4558_CR36","doi-asserted-by":"publisher","first-page":"3226","DOI":"10.2174\/092986711796391633","volume":"18","author":"J N\u00fa\u00f1ez","year":"2011","unstructured":"N\u00fa\u00f1ez J, Mi\u00f1ana G, Bod\u00ed V, N\u00fa\u00f1ez E, Sanchis J, Husser O, et al. Low lymphocyte count and cardiovascular diseases. Curr Med Chem. 2011;18(21):3226\u201333.","journal-title":"Curr Med Chem"},{"issue":"11","key":"4558_CR37","doi-asserted-by":"publisher","first-page":"2600","DOI":"10.1002\/jmv.26070","volume":"92","author":"M Ni","year":"2020","unstructured":"Ni M, Tian FB, Xiang DD, Yu B. Characteristics of inflammatory factors and lymphocyte subsets in patients with severe COVID-19. J Med Virol. 2020;92(11):2600\u20136.","journal-title":"J Med Virol"},{"issue":"1","key":"4558_CR38","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1067\/mhj.2001.115792","volume":"142","author":"D Acanfora","year":"2001","unstructured":"Acanfora D, Gheorghiade M, Trojano L, Furgi G, Pasini E, Picone C, et al. Relative lymphocyte count: a prognostic indicator of mortality in elderly patients with congestive heart failure. Am Heart J. 2001;142(1):167\u201373.","journal-title":"Am Heart J"},{"issue":"1","key":"4558_CR39","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1161\/01.CIR.97.1.19","volume":"97","author":"SR Ommen","year":"1998","unstructured":"Ommen SR, Hodge DO, Rodeheffer RJ, McGregor CG, Thomson SP, Gibbons RJ. Predictive power of the relative lymphocyte concentration in patients with advanced heart failure. Circulation. 1998;97(1):19\u201322.","journal-title":"Circulation"},{"issue":"2","key":"4558_CR40","first-page":"115","volume":"128","author":"B Szygu\u0142a-Jurkiewicz","year":"2018","unstructured":"Szygu\u0142a-Jurkiewicz B, Siedlecki \u0141, Pyka \u0141, Romuk E, Przyby\u0142owski P, G\u0105sior M. Red blood cell distribution width, relative lymphocyte count, and type 2 diabetes predict all\u2013cause mortality in patients with advanced heart failure. Pol Archives Intern Med. 2018;128(2):115\u201320.","journal-title":"Pol Archives Intern Med"},{"issue":"1","key":"4558_CR41","doi-asserted-by":"publisher","first-page":"758","DOI":"10.1186\/s12872-024-04446-1","volume":"24","author":"Y Wang","year":"2024","unstructured":"Wang Y, Wang L, Zhao Z, Yin S, Tang X, Zhang K. The predictive role of the hs-CRP\/HDL-C ratio for long-term mortality in the general population: evidence from a cohort study. BMC Cardiovasc Disord. 2024;24(1):758.","journal-title":"BMC Cardiovasc Disord"},{"issue":"1","key":"4558_CR42","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1186\/s12916-024-03810-4","volume":"22","author":"DTW Lui","year":"2024","unstructured":"Lui DTW, Li L, Liu X, Xiong X, Tang EHM, Lee CH, et al. The association of HDL-cholesterol levels with incident major adverse cardiovascular events and mortality in 0.6 million individuals with type 2 diabetes: a population-based retrospective cohort study. BMC Med. 2024;22(1):586.","journal-title":"BMC Med"},{"issue":"1","key":"4558_CR43","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1038\/nrcardio.2015.124","volume":"13","author":"RS Rosenson","year":"2016","unstructured":"Rosenson RS, Brewer HB Jr., Ansell BJ, Barter P, Chapman MJ, Heinecke JW, et al. Dysfunctional HDL and atherosclerotic cardiovascular disease. Nat Reviews Cardiol. 2016;13(1):48\u201360.","journal-title":"Nat Reviews Cardiol"},{"issue":"7\u20138","key":"4558_CR44","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1080\/07853890.2019.1694695","volume":"51","author":"CR Sirtori","year":"2019","unstructured":"Sirtori CR, Ruscica M, Calabresi L, Chiesa G, Giovannoni R, Badimon JJ. HDL therapy today: from atherosclerosis, to stent compatibility to heart failure. Ann Med. 2019;51(7\u20138):345\u201359.","journal-title":"Ann Med"},{"issue":"32","key":"4558_CR45","doi-asserted-by":"publisher","first-page":"2478","DOI":"10.1093\/eurheartj\/ehx163","volume":"38","author":"CM Madsen","year":"2017","unstructured":"Madsen CM, Varbo A, Nordestgaard BG. Extreme high high-density lipoprotein cholesterol is paradoxically associated with high mortality in men and women: two prospective cohort studies. Eur Heart J. 2017;38(32):2478\u201386.","journal-title":"Eur Heart J"},{"issue":"2","key":"4558_CR46","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1210\/clinem\/dgad406","volume":"109","author":"AC Razavi","year":"2024","unstructured":"Razavi AC, Jain V, Grandhi GR, Patel P, Karagiannis A, Patel N, et al. Does elevated high-density lipoprotein cholesterol protect against Cardiovascular Disease? J Clin Endocrinol Metab. 2024;109(2):321\u201332.","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"4558_CR47","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1002\/dmrr.1057","volume":"26","author":"MJ Haas","year":"2010","unstructured":"Haas MJ, Mooradian AD. Regulation of high-density lipoprotein by inflammatory cytokines: establishing links between immune dysfunction and cardiovascular disease. Diab\/Metab Res Rev. 2010;26(2):90\u20139.","journal-title":"Diab\/Metab Res Rev"},{"key":"4558_CR48","first-page":"28","volume-title":"Associations of plasma high-sensitivity C-reactive protein concentrations with all-cause and cause-specific mortality among middle-aged and elderly individuals","author":"ZH Li","year":"2019","unstructured":"Li ZH, Zhong WF, Lv YB, Kraus VB, Gao X, Chen PL, et al. Associations of plasma high-sensitivity C-reactive protein concentrations with all-cause and cause-specific mortality among middle-aged and elderly individuals. Volume 16. Immunity & ageing: I & A; 2019. p. 28."},{"key":"4558_CR49","doi-asserted-by":"publisher","first-page":"111079","DOI":"10.1016\/j.exger.2020.111079","volume":"141","author":"CM Shintouo","year":"2020","unstructured":"Shintouo CM, Mets T, Beckwee D, Bautmans I, Ghogomu SM, Souopgui J, et al. Is inflammageing influenced by the microbiota in the aged gut? A systematic review. Exp Gerontol. 2020;141:111079.","journal-title":"Exp Gerontol"},{"issue":"1","key":"4558_CR50","doi-asserted-by":"publisher","first-page":"147","DOI":"10.14336\/AD.2018.0326","volume":"10","author":"MG Flynn","year":"2019","unstructured":"Flynn MG, Markofski MM, Carrillo AE. Elevated inflammatory status and increased risk of Chronic Disease in Chronological Aging: Inflamm-aging or Inflamm-inactivity? Aging Disease. 2019;10(1):147\u201356.","journal-title":"Aging Disease"},{"issue":"2","key":"4558_CR51","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1093\/aje\/kwf024","volume":"156","author":"TB Harris","year":"2002","unstructured":"Harris TB. Invited commentary: body composition in studies of aging: new opportunities to better understand health risks associated with weight. Am J Epidemiol. 2002;156(2):122\u20134. discussion 5\u20136.","journal-title":"Am J Epidemiol"},{"key":"4558_CR52","doi-asserted-by":"publisher","first-page":"9076485","DOI":"10.1155\/2018\/9076485","volume":"2018","author":"F Olivieri","year":"2018","unstructured":"Olivieri F, Prattichizzo F, Grillari J, Balistreri CR. Cellular Senescence and Inflammaging in Age-Related diseases. Mediat Inflamm. 2018;2018:9076485.","journal-title":"Mediat Inflamm"},{"key":"4558_CR53","first-page":"637","volume":"6","author":"A Castoldi","year":"2015","unstructured":"Castoldi A, Naffah de Souza C, C\u00e2mara NO, Moraes-Vieira PM. The macrophage switch in obesity development. Front Immunol. 2015;6:637.","journal-title":"Front Immunol"},{"issue":"6","key":"4558_CR54","doi-asserted-by":"publisher","first-page":"1595","DOI":"10.1161\/01.ATV.20.6.1595","volume":"20","author":"K Hotta","year":"2000","unstructured":"Hotta K, Funahashi T, Arita Y, Takahashi M, Matsuda M, Okamoto Y, et al. Plasma concentrations of a novel, adipose-specific protein, adiponectin, in type 2 diabetic patients. Arterioscler Thromb Vasc Biol. 2000;20(6):1595\u20139.","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"1","key":"4558_CR55","first-page":"4","volume":"17","author":"JP Bastard","year":"2006","unstructured":"Bastard JP, Maachi M, Lagathu C, Kim MJ, Caron M, Vidal H, et al. Recent advances in the relationship between obesity, inflammation, and insulin resistance. Eur Cytokine Netw. 2006;17(1):4\u201312.","journal-title":"Eur Cytokine Netw"}],"container-title":["BMC Cardiovascular Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12872-025-04558-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12872-025-04558-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12872-025-04558-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,18]],"date-time":"2025-02-18T14:04:52Z","timestamp":1739887492000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccardiovascdisord.biomedcentral.com\/articles\/10.1186\/s12872-025-04558-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,18]]},"references-count":55,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["4558"],"URL":"https:\/\/doi.org\/10.1186\/s12872-025-04558-2","relation":{},"ISSN":["1471-2261"],"issn-type":[{"value":"1471-2261","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,18]]},"assertion":[{"value":"21 November 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 February 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 February 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The sections of this study that involved human participants, human material, or human data were done in line with the Declaration of Helsinki and approved by the National Center for Health Statistics (NCHS) Ethics Review Board. Patients\/participants gave written, informed consent to participate in this study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Clinical trial number"}},{"value":"The authors declare no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"111"}}